# Safety and Performance of the Glyconics-SX System (ANODE02)

> **NCT05476016** · NA · COMPLETED · sponsor: **Glyconics Ltd** · enrollment: 100 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Near-infrared (NIR)

## Key facts

- **NCT ID:** NCT05476016
- **Lead sponsor:** Glyconics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-29
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-12-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05476016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05476016, "Safety and Performance of the Glyconics-SX System (ANODE02)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05476016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*